|
JP Morgan Increases Price Target on LVS
|
JP Morgan Increases Price Target on LVS
This morning, Oppenheimer upgraded shares of Teva Pharmaceutical (TEVA) from perform to outperform following the release of Effexor XR.  The firm believes Effexor will add to the company’s earnings in the second half of 2010 and have set a price target of $65 per share.
Video Length: 0
Date Found: September 09, 2010
Date Produced: September 09, 2010
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|